Showing results (71-80 of 155) with videos related to
Sort By:
Pageof 16
Reviews of Infectious Diseases|July 1, 1983
Emergence of resistance during therapy with the newer beta-lactam antibiotics: role of inducible beta-lactamases and implications for the futureC C Sanders, W E SandersAntimicrobial Agents and Chemotherapy|January 1, 1990
Diverse potential of beta-lactamase inhibitors to induce class I enzymesD A Weber, C C SandersThe Journal of Infectious Diseases|November 1, 1982
Enocin: an antibiotic produced by Streptococcus salivarius that may contribute to protection against infections due to group A streptococciC C Sanders, W E SandersAntimicrobial Agents and Chemotherapy|May 1, 1999
Pharmacodynamics of trovafloxacin, ofloxacin, and ciprofloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic modelP D Lister, C C SandersAmerican Journal of Clinical Pathology|March 11, 1975
Effects of procedural variations on the activity of aminoglycosides in vitroC C Sanders, W E SandersThe Journal of Antimicrobial Chemotherapy|June 5, 2001
Pharmacodynamics of moxifloxacin, levofloxacin and sparfloxacin against Streptococcus pneumoniaeP D Lister, C C SandersAmerican Journal of Clinical Pathology|April 1, 1980
Antagonism of cefamandole by cefoxitin in routine disk susceptibility testsC C Sanders, W E SandersClinical Drug Investigation|August 14, 2016
Cefepime : The Last Generation or the First Enhanced-Potency Broad Spectrum Cephalosporin?C C Sanders, E S MolandPlant Physiology|October 1, 1983
Isolation of ;Vacuoplasts' from Poterioochromonas malhamensisP Jochem, K S Thomson, D SchwabPlanta|January 31, 2014
In-vitro auxin binding to particulate cell fractions from corn coleoptilesR Hertel, K S Thomson, V E RussoPageof 16